Andrew C. Weiss
Investor Relations Kontakt bei IDORSIA LTD
Aktive Positionen von Andrew C. Weiss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IDORSIA LTD | Investor Relations Kontakt | 01.06.2017 | - |
Public Communications Contact | 01.06.2017 | - |
Karriereverlauf von Andrew C. Weiss
Ehemalige bekannte Positionen von Andrew C. Weiss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACTELION | Investor Relations Kontakt | 05.05.2014 | 01.01.2017 |
Public Communications Contact | 05.05.2014 | 01.01.2017 | |
Bank Sarasin & Cie AG (Broker) | Analyst-Equity | - | 01.05.2007 |
Julius Baer Holding AG | Corporate Officer/Principal | 01.01.2000 | 01.01.2005 |
Bank Vontobel AG (Research Firm) | Analyst-Equity | - | - |
Ausbildung von Andrew C. Weiss
University of Zurich | Graduate Degree |
Statistik
International
Schweiz | 7 |
Operativ
Analyst-Equity | 2 |
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Sektoral
Finance | 4 |
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IDORSIA LTD | Health Technology |
Private Unternehmen | 4 |
---|---|
Bank Sarasin & Cie AG (Broker) | Finance |
Bank Vontobel AG (Research Firm) | Finance |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Julius Baer Holding AG | Finance |
- Börse
- Insiders
- Andrew C. Weiss
- Erfahrung